Clinical trials
Recruiting Lung Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
836 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 4 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 6 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 7 |
| 2017 | 9 |
| 2018 | 21 |
| 2019 | 18 |
| 2020 | 23 |
| 2021 | 36 |
| 2022 | 73 |
| 2023 | 120 |
| 2024 | 150 |
| 2025 | 198 |
| 2026 | 145 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 836 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 20 |
| National Cancer Institute (NCI) | 15 |
| Massachusetts General Hospital | 12 |
| Second Affiliated Hospital of Guangzhou Medical University | 12 |
| Shanghai Chest Hospital | 11 |
| Mayo Clinic | 10 |
| Sun Yat-sen University | 9 |
| Assistance Publique - Hôpitaux de Paris | 8 |
| AstraZeneca | 8 |
| Shanghai Pulmonary Hospital, Shanghai, China | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 836 |
| Carcinoma, Non-Small-Cell Lung | 246 |
| Breast Neoplasms | 119 |
| Neoplasms | 84 |
| Colorectal Neoplasms | 77 |
| Pancreatic Neoplasms | 73 |
| Stomach Neoplasms | 57 |
| Ovarian Neoplasms | 55 |
| Prostatic Neoplasms | 51 |
| Melanoma | 48 |
Trials
Showing 26 to 50 of 836. Each trial links to its page on Pharma Observatory.
736 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.